Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma

被引：0
|
作者：
Nicole Huge
Maria Sandbothe
Anna K. Schröder
Amelie Stalke
Marlies Eilers
Vera Schäffer
Brigitte Schlegelberger
Thomas Illig
Beate Vajen
Britta Skawran
机构：
[1] Hannover Medical School,Department of Human Genetics
来源：
Hepatology International | 2020年 / 14卷
关键词：
Liver cancer; B9L; BCL9-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：373 / 384
页数：11
相关论文
共 50 条
  • [31] BCL9L DYSFUNCTION PROMOTES ANEUPLOIDY TOLERANCE IN COLON TUMORS
    不详
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 245 - 245
  • [32] A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
    Tanton, Helen
    Sewastianik, Tomasz
    Seo, Hyuk-Soo
    Remillard, David
    St Pierre, Roodolph
    Bala, Pratyusha
    Aitymbayev, Daulet
    Dennis, Peter
    Adler, Keith
    Geffken, Ezekiel
    Yeoh, Zoe
    Vangos, Nicholas
    Garbicz, Filip
    Scott, David
    Sethi, Nilay
    Bradner, James
    Dhe-Paganon, Sirano
    Carrasco, Ruben D.
    [J]. SCIENCE ADVANCES, 2022, 8 (17)
  • [33] Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
    David M. Gay
    Rachel A. Ridgway
    Miryam Müller
    Michael C. Hodder
    Ann Hedley
    William Clark
    Joshua D. Leach
    Rene Jackstadt
    Colin Nixon
    David J. Huels
    Andrew D. Campbell
    Thomas G. Bird
    Owen J. Sansom
    [J]. Nature Communications, 10
  • [34] SOX7 Suppresses Wnt Signaling by Disrupting -Catenin/BCL9 Interaction
    Fan, Rong
    He, HaiYan
    Yao, Wang
    Zhu, YanFeng
    Zhou, XunJie
    Gui, MingTai
    Lu, Jing
    Xi, Hao
    Deng, ZhongLong
    Fan, Min
    [J]. DNA AND CELL BIOLOGY, 2018, 37 (02) : 126 - 132
  • [35] BCL9L and caspase-2-new guardians against aneuploidy
    Chunduri, Narendra Kumar
    Storchova, Zuzana
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S139 - S142
  • [36] Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer (vol 10, 723, 2019)
    Gay, David M.
    Ridgway, Rachel A.
    Mueller, Miryam
    Hodder, Michael C.
    Hedley, Ann
    Clark, William
    Leach, Joshua D.
    Jackstadt, Rene
    Nixon, Colin
    Huels, David J.
    Campbell, Andrew D.
    Bird, Thomas G.
    Sansom, Owen J.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [37] BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy Invited Commentary
    Doherty, Gerard M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (06) : 995 - 995
  • [38] LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction (vol 5, pg 1650, 2013)
    Li, Jiong
    Chen, Xiaohong
    Ding, Xiangming
    Cheng, Yingduan
    Zhao, Bin
    Lai, Zhi-chun
    Al Hezaimi, Khalid
    Hakem, Razqallah
    Guan, Kun-liang
    Wang, Cun-Yu
    [J]. CELL REPORTS, 2020, 31 (11):
  • [39] Identification of BCL9L as a Novel Heterotaxy Gene by Whole Genome Sequencing of a Quartet
    Saunders, C.
    Miller, N.
    Soden, S.
    Dinwiddie, D.
    Noll, A.
    Humphray, S.
    Saffrey, P.
    Kingsbury, Z.
    Betley, J.
    Grocock, R.
    Safina, N.
    Petrikin, J.
    Hall, K.
    Kingsmore, S. F.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 643 - 643
  • [40] Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
    Chao Yang
    Yonghua Xu
    Feng Cheng
    Yuanchang Hu
    Shikun Yang
    Jianhua Rao
    Xuehao Wang
    [J]. Cell Death & Disease, 14
12345